Transfer factor has been studied extensively in humans, but a satisfactory subprimate model has not been established. Using BALB/c mice immunized with complete Freund adjuvant, we show that a low-molecular-weight substance derived from disrupted spleen cells transferred sensitivity to purified protein derivative (PPD) to recipient nonimmunized BALB/c mice. Transfer was confirmed by footpad swelling to PPD in vivo and by splenic lymphocyte transformation to PPD in vitro. In recipients of transfer factor, an inverse correlation was noted between the splenic lymphocyte response to PPD and to concanavalin A. Material obtained from spleens of saline-treated BALB/c mice did not transfer sensitivity to PPD to recipient mice.
Lawrence reported in 1955 that disrupted leukocytes from a sensitized human donor yielded a low-molecular-weight dialyzable substance designated transfer factor (TF), which could transfer delayed-type hypersensitivity (DTH) to a nonimmune recipient (13) . The existence of TF in humans has been confirmed repeatedly by other workers (2, 10) . TF has been used therapeutically in patients with tumors (14) , disseminated fungal infections (11) , and certain immunodeficiency diseases (22) . However, investigation of the mechanism of transfer and standardization of the potency ofvarious TF preparations has been slowed by the lack of a suitable animal model.
Extensive study by several workers in the 1960s failed to show dialyzable TF in guinea pigs (1), although Jeter et al. described transfer of sensitivity with disrupted leukocytes in guinea pigs in 1954 (9) . More recent studies using cows (12) , rats (15) , dogs (21) , and guinea pigs (3) have led to renewed interest in a subprimate model for the study of TF. Rifkind et al. (19) have shown that a TF-like substance derived from murine spleen cells can transfer DTH as measured by footpad swelling. Our studies confirm the existence of a low-molecular-weight substance derived from murine spleen cells which is able to pass DTH to recipient mice; we further show that transfer is associated with the development of in vitro lymphocyte transformation to the antigen to which TF donors have been sensitized. did not respond in vitro to PPD. Among 60 animals, only 4 had an SI of >3.0, and the mean SI for the three groups was <2.0. Animals receiving TFs showed a mean SI to PPD of 6.0; 19 of 36 mice responded to the antigen. The difference between the response to PPD of TFs and TFN recipients was highly significant (P < 0.001). All CFA-immunized mice except one responded to PPD in vitro. Only 6 of 14 recipients of immune spleen cells showed stimulation to PPD, possibly reflecting poor recirculation from the peritoneal to the splenic pool of cells. Among the TFs animals there was no correlation between footpad response to PPD and in vitro lymphocyte transformation to PPD. Mean background deoxyribonucleic acid synthesis in counts per minute in 6-day cultures without antigen was as follows: saline-treated mice, 3,094; normal spleen cell recipients, 7,044; TFN recipients, 7,702; CFA-treated mice, 1,838; sensitized cell recipients, 7,365; and TFs recipients, 5,262.
Transformation to the mitogen ConA was studied simultaneously with the PPD response in all groups (Fig. 2) . The mean SI was approximately 30 in all control groups. None of the CFA-immunized animals or the recipients of immune spleen cells responded to ConA. Among TFs recipients, 17 of 34 had a very poor mitogenic response (SI < 10), whereas 17 had an SI between 10 and 40. When individual TFs animals were scrutinized for their responses to PPD and to ConA, there was an inverse correlation noted between the two tests (correlation coefficient = -0.65; P < 0.001) (Fig. 3) . Those animals that showed specific transformation to PPD, in general, did not respond to ConA. The best ConA response was found in those animals that did not respond to PPD. Mean background deoxyribonucleic acid synthesis in counts per minute in 3-day cultures without mitogen ranged between 2,550 and 3,500 for saline-treated mice, normal-cell recipients, sensitized-cell recipients, and TFN recipients. Mean spontaneous transformation was 6,070 for TFs recipients and 12,034 for CFA-immunized mice.
MIF activity was assessed in all groups of animals ( Table 2 ). The TFs recipients as well as the positive control groups showed inhibition of macrophage migration. However, the specificity of this inhibition is questionable since four of four groups of normal-cell recipients and four of eight groups of TFN recipients also showed >20% inhibition of migration. (19) . They also confirmed Crowle's earlier work showing that footpad swelling is a valid indicator of DTH in mice (7, 17) . Both the study of Rifkind et al. and ours used complex microbial antigens. Both documented transfer by in vivo footpad swelling. Additionally, we showed development of in vitro responsiveness to PPD after TF administration.
The TF-like substance we found in BALB/c spleen cells has not been biochemically characterized; the preparation of Rifkind et al. from CF1 spleen cells was resistant to deoxyribonuclease, ribonuclease, and trypsin and sensitive to pronase and phosphodiesterase, properties shared with human TF (18) . It is possible that antigen could have been transferred to recipients in the TFs preparation and that active sensitization occurred in these animals. However, this seems unlikely in view of the short time between TFs administration and evaluation of footpad and lymphocyte transformation responses. It has been shown by others using animal systems that TF does not transfer antigen (3) .
That TF is unique to humans and other primates seems untenable since so many immunological phenomena are shared by most mammals (4). Besides the above studies in mice, TF has now been demonstrated in cattle (12) , rats (15) , dogs (21) , and guinea pigs (3) . Although several of these models used Lawrence's method to prepare dialyzable material from disrupted leukocytes (15, 21) , others used material released into the supernatant by sensitized cells incubated at 370C for 4 h (3, 12) . Assays for transfer of sensitivity have included both skin test reactivity and in vitro lymphocyte transformation in sev-INFECT. IMMUN. eral of these models (12, 21) as well as in our murine model.
In this study, transfer of sensitivity appeared to be specific in that TFN recipients did not show a response to PPD. However, specificity should be evaluated further by testing recipient animals with footpad responses and lymphocyte transformation to several different antigens. In both footpad swelling and transformation assays, the responsiveness shown by CFA-immunized animals was greater than that exhibited by the TFs recipients. The poor transformation response to PPD noted by recipients of immune spleen cells may be related to poor circulation to the spleen by the cells given i.p. (5); these animals responded the best of all groups in the MIF assay, which used cells from the peritoneum.
Not all animals given TFs reacted to PPD by footpad swelling or lymphocyte transformation; it appeared that some preparations of TFs were more active than others in transferring immunity. Without an adequate method to standardize the quantity of TF given, this has been a recurrent problem in most TF studies (8) .
Spleen cells of CFA-immunized mice did not respond to ConA, whereas saline-treated mice responded normally to this mitogen. Likewise, recipients of immune spleen cells showed no response to ConA, whereas recipients of nonimmune cells reacted well. This inhibition of spleen cell mitogenic response could reflect activation of a population of suppressor cells in the spleens, as has been found in mice given Mycobacterium bovis BCG i.p. or intravenously (25) or Corynebacteriumparvum (20) . Those animals receiving TFs that showed transfer of sensitivity to PPD by in vitro lymphocyte transformation responded poorly to ConA, implying that the process responsible for suppression occurred in these animals as well. TFs animals that did not respond to PPD responded well to ConA, and TFN recipients responded well to ConA.
In the system we used, PPD was a specific antigen and not a mitogen for murine spleen cells. No saline-treated animals responded to PPD, whereas all except one animal immunized with CFA responded to PPD. Sultzer et al. have reported that PPD is a mitogen for murine spleen cells (23, 24) , but this effect was noted at 48 to 72 h, not 144 h, and occurred at larger doses of PPD than we used. Other workers have not found PPD to be a nonspecific mitogen in mice (16) .
The direct MIF assay as used in this study appeared to be nonspecific. Intraperitoneal administration of either whole cells or TF, either normal or sensitized, led to inhibition of macrophage migration. Although recipients of TFs on October 27, 2017 by guest http://iai.asm.org/ Downloaded from showed greater inhibition of migration, this was not significantly different from results with recipients of TFN. The cause of this nonspecificity is not known, but may relate to the use of the peritoneal cavity for administration of cells or TF as well as the procurement of macrophages. This problem could be obviated by an indirect MIF assay using other animal's macrophages as indicator cells.
These studies establish that a TF-like substance does exist in murine spleen cells, and that sensitivity to at least one microbial antigen can be transferred with this moiety. Biochemical characterization of this substance and its relation both to the material obtained by Rifkind et al. (19) in a different inbred mouse strain and to human TF will be of interest. Further studies with other antigens will also be important. Finally, this model should be quite useful in investigating the mode of action of TF.
